P16-46. CD8+ T cells from nonlymphoid tissues exhibit superior control of SIV replication by Greene, JM et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
P16-46. CD8+ T cells from nonlymphoid tissues exhibit superior 
control of SIV replication
JM Greene*, JJ Lhost, BJ Burwitz, SL O'Connor and DH O'Connor
Address: Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
* Corresponding author    
Background
CD8+ T cells are vital to controlling HIV replication in
humans and SIV infection in nonhuman primates. How-
ever, several studies provided conflicting evidence about
the role of CD8+ T cells in effective or complete control of
viral replication. The vast majority of these studies use
lymphocytes isolated from blood in assays that provide
indirect measures of CD8+ T cell function including ELIS-
pot or ICS. Here we assess lymphocyte function using ex
vivo viral suppression assays that directly test the ability of
lymphocytes to suppress viral replication.
Methods
Unlike several previous studies using cell lines or clonally
derived cells, we assess CD8+ T cell function from freshly
isolated lymphocytes. We isolated CD8+ T cells from lung
bronchoalveolar lavage or blood and used them as effec-
tor cells combined with CD8-depleted, SIV-infected target
cells. After several days in culture we assessed each well by
flow cytometry for p27+ cells to determine which effector
cells were the most functional ex vivo.
Results
Lung CD8+ T cells isolated from infected animals sup-
pressed viral replication better than CD8+ T cells isolated
from the blood. Sufficient numbers of cells were always
collected from brochoalveolar lavage during these experi-
ments. Even though, by the end of the assay, there were
generally fewer CD8+ T cells in the wells using lung lym-
phocytes, they were still the most effective at suppressing
viral replication.
Conclusion
We demonstrate that there are significant differences in
the ability of cells to suppress viral replication depending
on their tissue of origin. These results further emphasize
the need to understand the mucosal immune response,
and suggest researchers may be missing important corre-
lates of protection by focusing on assays using cells iso-
lated from the blood.
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